Black Raspberry Extract Enhances LDL Uptake in HepG2 Cells by Suppressing PCSK9 Expression to Upregulate LDLR Expression

논문상세정보
    • 저자 송광훈 김영화 임아랑 김윤희
    • 제어번호 106023386
    • 학술지명 Journal of medicinal food
    • 권호사항 Vol. 21 No. 6 [ 2018 ]
    • 발행처 한국식품영양과학회
    • 자료유형 학술저널
    • 수록면 560-567
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 판매처
    유사주제 논문( 0)

' Black Raspberry Extract Enhances LDL Uptake in HepG2 Cells by Suppressing PCSK9 Expression to Upregulate LDLR Expression' 의 참고문헌

  • The proprotein convertases are potential targets in the treatment of dyslipidemia
    Seidah NG [2007]
  • The biology and therapeutic targeting of the proprotein convertases
    Seidah NG [2012]
  • Targeting heme oxygenase-1 in vascular disease
    Durante W [2010]
  • Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia
    Dubuc G [2004]
  • Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice
    Lagace TA [2006]
  • Quercetin up-regulates LDL receptor expression in HepG2 cells
    Moon J [2012]
  • Proprotein convertase subtilisin/kexin type 9 (PCSK9): Hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration
    Zaid A [2008]
  • Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: Present perspectives and future horizons
    Yadav K [2016]
  • Phaleria macrocarpa (Scheff.) Boerl fruit aqueous extract enhances LDL receptor and PCSK9 expression in vivo and in vitro
    Chong SC [2011]
  • Peroxisome proliferator-activated receptor gamma activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression
    Duan Y [2012]
  • PCSK9: A convertase that coordinates LDL catabolism
    Horton JD [2009]
  • Open-label study of long-term evaluation against LDLCI. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events
    Sabatine MS [2015]
  • New therapies for reducing low-density lipoprotein cholesterol
    Stein EA [2014]
  • Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote
    Zhao Z [2006]
  • Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9
    Cohen J [2005]
  • Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1alpha protein expression through the ubiquitin-proteasome degradation pathway
    Dong B [2015]
  • Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c
    Costet P [2006]
  • Heme oxygenase-1: A novel therapeutic target for gastrointestinal diseases
    Naito Y [2011]
  • Glucagon and cAMP inhibit cholesterol 7alpha-hydroxylase (CYP7A1) gene expression in human hepatocytes: Discordant regulation of bile acid synthesis and gluconeogenesis
    Song KH [2006]
  • Effects of black raspberry on lipid profiles and vascular endothelial function in patients with metabolic syndrome
    Jeong HS [2014]
  • Dual mechanisms for the fibrate-mediated repression of proprotein convertase subtilisin/kexin type 9
    Kourimate S [2008]
  • Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages
    Park SH [2011]
  • Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells
    Tai MH [2014]
  • Berberine decreases PCSK9 expression in HepG2 cells
    Cameron J [2008]
  • Benefits of blackberry nectar (Rubus spp.) relative to hypercholesterolemia and lipid peroxidation
  • Antioxidant activity in fruits and leaves of blackberry, raspberry, and strawberry varies with cultivar and developmental stage
    Wang SY [2000]
  • Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype
    Maxwell KN [2004]
  • A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates
    Chan JC [2009]